Retail sale of pharmaceutical products
FIZ PHARMA AS
Revenue 2024
NOK 19.0m
Operating profit
NOK 2.1m
Equity
NOK 3.2m
Incorporated
2020
Employees
5
Share capital
NOK 30,000
Key figures · 2024
Current ratio
1.82
Equity ratio
55.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 11.1% | |
| Net margin (%%) | 8.7% | |
| Return on assets (%%) | 35.9% | |
| Likviditet | ||
| Current ratio | 1.82 | |
| Working capital | 2.1m | |
| Soliditet | ||
| Equity ratio (%%) | 55.3% | |
| Debt-to-equity ratio | 0.81 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.